Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion

Obstetrics and Gynecology

Volumn 109, Issue 4, 2007, Pages 895-901

  Bracken, Hillary ^a   Ngoc, Nguyen Thi Nhu ^b   Schaff, Eric ^b   Coyaji, Kurus ^b   Ambardekar, Shubha ^b   Westheimer, Emily ^b   Winikoff, Beverly ^b  

^a GYNUITY HEALTH PROJECTS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; MIFEPRISTONE; MISOPROSTOL;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; THERAPEUTIC ABORTION; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; VOMITING; WEAKNESS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34147131186     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000259319.18958.76     Document Type: Article

References (17)

1. Koonin LM, Strauss LT, Chrisman CE, Montalbano MA, Bartlett LA, Smith JC. Abortion Surveillance-United States, 1996. MMWR Surveill Summ 1999;48:1-42.
2. Ahman E, Shah I. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000. 4th ed. Geneva (Switzerland): World Health Organization; 2004. Available at: http://www.who.int/reproductive-health/publications/ unsafe_abortion_estimates_04/estimates.pdf. Retrieved January 31, 2007.
3. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000;61:41-46.
4. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1-6.
5. Schaff EA, Fielding SL, Westoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000;284:1948-53.
6. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13:2962-5.
7. Gemzell-Danielsson K, Ostlund E. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases. Acta Obstet Gynecol Scand 2000;79:702-6.
8. Gouk EV, Lincoln K, Khair A, Haslock J, Knight J, Cruickshank DJ. Medical termination of pregnancy at 63 to 83 days gestation. Br J Obstet Gynaecol 1999;106:535-9.
9. Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet 1998;352:542-3.
10. Cheng L. Termination of 10-16 week's gestation with mifepristone plus misoprostol: a multicentre randomized clinical trial [in Chinese]. Zhonghua Fu Chan Ke Za Zhi 1999;34:268-71.
11. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Human Reprod 2002;17:92-8.
12. Hamoda H, Ashok PW, Flett GM, Templeton A. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases. Am J Obstet Gynecol 2003;188:1315-9.
13. Hamoda H, Ashok PW, Flett GM, Templeton A. Medical abortion at 9-13 week's gestation: a review of 1076 consecutive cases. Contraception 2005;71:327-32.
14. Hamoda H, Ashok PW, Flett GM, Templeton A. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. BJOG 2004;111:996-1000.
15. Penney G. Treatment of pain during medical abortion. Contraception 2006;74:45-7.
16. Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997;104:829-33.
17. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med 1998;7:360-6.